David Ricks, Chair and Chief Executive Officer of Eli Lilly, noted that fewer than one in ten people who could benefit from a GLP-1 therapy are currently taking one, citing access barriers, stigma, and the complexity of existing treatment options
FedEx shipping is horrible
Separate retrospective cohort studies carried out by Apart from this, previous studies have also examined the specific influence of GLP-1RAs on IOP changes, RGCs survival, etc
That is why protein intake, strength training, and proper coaching are important parts of a well-rounded plan
The honest answer is somewhere in between, and worth understanding clearly before assuming its either essential or irrelevant